ClinicalTrials.gg
Drug

Dasatinib clinical trials

Also written Sprycel and BMS-354825.

studies test it
279
open now
25
in phase 3
18
first study started
2001

How each study uses Dasatinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Dasatinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Jun 2006 · SPRYCEL · NDA 021986 (FDA, Drugs@FDA)
European Union
26 Jul 2024 · Dasatinib Accord Healthcare · EMEA/H/C/006251 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dasatinib
233
Dasatinib Hydrate
21
Dasatinib Monohydrate
21
Dasatinib (BMS-354825)
3
dasatinib (SPRYCEL®)
3

Brand

Sprycel
161

Development codes

BMS-354825
109
BMS-354825-03
1

In one entry with another drug

Given together, or one or the other

Dasatinib + Quercetin
3
Dasatinib plus Quercetin
2
D+Q
2

Studies by the year they started

277 studies that test it; most in 2007 (37); 1 more planned to start later

Studies that test Dasatinib, by start year
YearStudies
20011
20032
20044
200511
200615
200737
200824
200934
20106
201113
201216
20139
201410
201512
201617
20178
20184
20192
20208
20217
202210
20239
20247
20258
20263

Who runs them

Industry 56 · Other 223

Bristol-Myers Squibb (49) · National Cancer Institute (NCI) (31) · M.D. Anderson Cancer Center (21) · Mayo Clinic (6) · Duke University (6) · St. Jude Children's Research Hospital (5) · Memorial Sloan Kettering Cancer Center (4) · Washington University School of Medicine (4)

Often tested with

Tested in the same studies.

Imatinib (19) · Quercetin (19) · Erlotinib (10) · Cytarabine (9) · Nilotinib (9) · Prednisone (8) · Methotrexate (7) · Dexamethasone (7)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Dasatinib is the comparator. A study of two new drugs counts under both.

  • 1Asciminib · Novartis Pharmaceuticals
  • 1Embibatinib · Jiangsu Hansoh Pharmaceutical Co., Ltd. · next primary completion Jul 2029
Reaching primary completion within a year · 13, 1 in phase 3

Studies that test Dasatinib, phase 3 first.

Studies

Open first, then newest update. How each study uses Dasatinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 279

See all 279 studies that test Dasatinib →

Given beside what is tested · 33 — Dasatinib is usual care or a partner of the new treatment

Showing 20 of 33.

As the comparator · 4 — what is tested is compared with Dasatinib

Codes

What other systems call Dasatinib · ClinicalTrials.gg INT006575

  • MeSH (NLM) D000069439DasatinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) RBZ1571X5HDASATINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 475342Confirmed FDA, Wikidata
  • Wikidata Q27139135dasatinib monohydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C38713DasatinibConfirmed FDA, Wikidata

Also registered as dasatinib anhydrous (UNII X78UG0A0RN · RxNorm 1546019).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.